IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Home (in Vivo)

IV_new_banner3new_highwire_logo

PRINT ISSN: 0258-851X
ONLINE ISSN: 1791-7549

During the current pandemic, efficient sharing of information is extremely important. For this reason, all articles for the Covid-19 Special Issue will be uploaded here ahead of print as soon as they have been peer-reviewed. The issue will be formally published in June 2020 and will be accessible on In Vivo’s website through Highwire Press.

CALL FOR PAPERS
IN VIVO Special Issue On SARS-Cov-2 and Covid-19 Disease

TOPICS: Reviews, experimental and clinical articles on all aspects of SARS-Cov-2 and Covid-19 disease.

Deadline for article submission: 18 May 2020
Publication Policy: Submitted articles should not exceed 20 typewritten pages plus figures and tables.

  • All submitted manuscripts will be rapidly peer-reviewed within 3-5 days, and Authors will be immediately noticed if a revision is requested. Revised manuscripts should reach our office within 24-48 hours. Prompt arrangements focus on the rapid publication of this issue online OPEN ACCESS in the Highwire-IN VIVO site on June 2, 2020.
  • All accepted papers will be subject to a publication fee of US$ 250.00. Color figures will be published free of charge.
  • Manuscripts should follow our Instructions to Authors and should be submitted electronically (www.iiar-submissions.com).

Information: Dr. George J. Delinasios, e-mail: journals@iiar-anticancer.org

In Vivo is an international journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of human physiology, pathology and disease management. IN VIVO was established in 1987 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, submission of manuscripts, contents of previous volumes and a current list of accepted manuscripts.

From January 2017 In Vivo is published online – only with open access through Stanford University HighWire Press. Free online access of Full-text or PDF (from January 2009), or PDF-only (from January 2004 to December 2008) articles will be available through Stanford University HighWire Press. Articles published before 2004 (Volumes 1/1987 – 17/2003) are available through the Editorial Office.

Impact factor (2019): 1.609
Total articles: 234
Total cites: 2,875

Now the entire contents of In Vivo published from 2013 till today
can be accessed for free from Android, iPhone, iPad and compatible Chromebook devices.


Contents of Current Issue

Archive of All Online Issues (January 2004 – Present)

  • 1987 – 2019
  • 33 volumes
  • over 27,000 pages
  • over 4,100 original articles and reviews
  • over 27,800 authors
  • conference abstracts
  • special issues
  • author and subject detailed indexes
  • included in Pubmed and most abstracting services
  • online open access with Stanford University HighWire Press
  • safe processing of all submitted manuscripts
  • rapid publication within 1-2 months of acceptance
  • no fees for language and style corrections
  • immediate contact with the Editorial Office

ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
e-mail: journals@iiar-anticancer.org

Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389
e-mail:journals@iiar-anticancer.org

IMPORTANT NOTE: You may submit your article only through our online submission system